158 related articles for article (PubMed ID: 36479659)
21. Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on Cancer Stage.
Waters JA; Schnelldorfer T; Aguilar-Saavedra JR; Chen JH; Yiannoutsos CT; Lillemoe KD; Farnell MB; Sarr MG; Schmidt CM
J Am Coll Surg; 2011 Aug; 213(2):275-83. PubMed ID: 21601488
[TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics, treatment patterns and survival outcomes of early-onset pancreatic adenocarcinoma: a population-based study.
Ren S; Sadula A; Ye C; Chen Q; Yuan M; Meng M; Lei J; Li G; Yuan C
Am J Transl Res; 2023; 15(1):407-421. PubMed ID: 36777821
[TBL] [Abstract][Full Text] [Related]
23. Early-onset pancreatic cancer: A national cancer registry study from the Czech Republic and review of the literature.
Whitley A; Kocián P; Nikov A; Krejčí D; Pehalová L; Blaha M; Dušek L; Gürlich R
J Hepatobiliary Pancreat Sci; 2023 Dec; 30(12):1324-1333. PubMed ID: 37750364
[TBL] [Abstract][Full Text] [Related]
24. Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma.
Pointer DT; Roife D; Powers BD; Murimwa G; Elessawy S; Thompson ZJ; Schell MJ; Hodul PJ; Pimiento JM; Fleming JB; Malafa MP
BMC Cancer; 2020 Aug; 20(1):750. PubMed ID: 32782024
[TBL] [Abstract][Full Text] [Related]
25. Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation.
Estrella JS; Rashid A; Fleming JB; Katz MH; Lee JE; Wolf RA; Varadhachary GR; Pisters PW; Abdalla EK; Vauthey JN; Wang H; Gomez HF; Evans DB; Abbruzzese JL; Wang H
Cancer; 2012 Jan; 118(1):268-77. PubMed ID: 21735446
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of adjacent organ resection in patients with left-sided pancreatic ductal adenocarcinoma following distal pancreatectomy.
Song KB; Kwon J; Kim YW; Hwang DW; Lee JH; Hong S; Lee JW; Hwang K; Yoo D; Kim SC
J Hepatobiliary Pancreat Sci; 2019 Jun; 26(6):227-234. PubMed ID: 30980486
[TBL] [Abstract][Full Text] [Related]
27. Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma.
Malleo G; Maggino L; Ferrone CR; Marchegiani G; Luchini C; Mino-Kenudson M; Paiella S; Qadan M; Scarpa A; Lillemoe KD; Bassi C; Fernàndez-Del Castillo C; Salvia R
Ann Surg Oncol; 2020 Oct; 27(10):3898-3912. PubMed ID: 32307617
[TBL] [Abstract][Full Text] [Related]
28. Outcome after resection for invasive intraductal papillary mucinous neoplasia is similar to conventional pancreatic ductal adenocarcinoma.
Holmberg M; Ghorbani P; Gilg S; Del Chiaro M; Arnelo U; Löhr JM; Sparrelid E
Pancreatology; 2021 Oct; 21(7):1371-1377. PubMed ID: 34426077
[TBL] [Abstract][Full Text] [Related]
29. Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma.
Shin DW; Lee JC; Kim J; Woo SM; Lee WJ; Han SS; Park SJ; Choi KS; Cha HS; Yoon YS; Han HS; Hong EK; Hwang JH
Eur J Surg Oncol; 2019 Nov; 45(11):2159-2165. PubMed ID: 31202572
[TBL] [Abstract][Full Text] [Related]
30. Adverse Oncologic Impact of New-Onset Diabetes Mellitus on Recurrence in Resected Pancreatic Ductal Adenocarcinoma: A Comparison With Long-standing and Non-Diabetes Mellitus Patients.
Lee S; Hwang HK; Kang CM; Lee WJ
Pancreas; 2018 Aug; 47(7):816-822. PubMed ID: 29975349
[TBL] [Abstract][Full Text] [Related]
31. Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma.
Crippa S; Pergolini I; Javed AA; Honselmann KC; Weiss MJ; Di Salvo F; Burkhart R; Zamboni G; Belfiori G; Ferrone CR; Rubini C; Yu J; Gasparini G; Qadan M; He J; Lillemoe KD; Castillo CF; Wolfgang CL; Falconi M
Ann Surg; 2022 Aug; 276(2):378-385. PubMed ID: 33086324
[TBL] [Abstract][Full Text] [Related]
32. Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis.
Tachezy M; Gebauer F; Janot M; Uhl W; Zerbi A; Montorsi M; Perinel J; Adham M; Dervenis C; Agalianos C; Malleo G; Maggino L; Stein A; Izbicki JR; Bockhorn M
Surgery; 2016 Jul; 160(1):136-144. PubMed ID: 27048934
[TBL] [Abstract][Full Text] [Related]
33. Implications of the Pattern of Disease Recurrence on Survival Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma.
Groot VP; Gemenetzis G; Blair AB; Ding D; Javed AA; Burkhart RA; Yu J; Borel Rinkes IH; Molenaar IQ; Cameron JL; Fishman EK; Hruban RH; Weiss MJ; Wolfgang CL; He J
Ann Surg Oncol; 2018 Aug; 25(8):2475-2483. PubMed ID: 29948425
[TBL] [Abstract][Full Text] [Related]
34. International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer.
van Roessel S; Kasumova GG; Verheij J; Najarian RM; Maggino L; de Pastena M; Malleo G; Marchegiani G; Salvia R; Ng SC; de Geus SW; Lof S; Giovinazzo F; van Dam JL; Kent TS; Busch OR; van Eijck CH; Koerkamp BG; Abu Hilal M; Bassi C; Tseng JF; Besselink MG
JAMA Surg; 2018 Dec; 153(12):e183617. PubMed ID: 30285076
[TBL] [Abstract][Full Text] [Related]
35. Accurate Nodal Staging in Pancreatic Cancer in the Era of Neoadjuvant Therapy.
Javed AA; Ding D; Baig E; Wright MJ; Teinor JA; Mansoor D; Thompson E; Hruban RH; Narang A; Burns WR; Burkhart RA; Lafaro K; Weiss MJ; Cameron JL; Wolfgang CL; He J
World J Surg; 2022 Mar; 46(3):667-677. PubMed ID: 34994834
[TBL] [Abstract][Full Text] [Related]
36. The diversity between curatively resected pancreatic head and body-tail cancers based on the 8th edition of AJCC staging system: a multicenter cohort study.
Sheng W; Dong M; Wang G; Shi X; Gao W; Wang K; Song H; Shi G; Tan X
BMC Cancer; 2019 Oct; 19(1):981. PubMed ID: 31640615
[TBL] [Abstract][Full Text] [Related]
37. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
[TBL] [Abstract][Full Text] [Related]
38. Identification of intratumoral fluid-containing area by magnetic resonance imaging to predict prognosis in patients with pancreatic ductal adenocarcinoma after curative resection.
Kim H; Kim DH; Song IH; Youn SY; Kim B; Oh SN; Choi JI; Rha SE
Eur Radiol; 2022 Apr; 32(4):2518-2528. PubMed ID: 34671833
[TBL] [Abstract][Full Text] [Related]
39. Association of preoperative total lymphocyte count with prognosis in resected left-sided pancreatic cancer.
Rho SY; Hwang HK; Chong JU; Yoon DS; Lee WJ; Kang CM
ANZ J Surg; 2019 May; 89(5):503-508. PubMed ID: 30836428
[TBL] [Abstract][Full Text] [Related]
40. CA19-9 on Postoperative Surveillance in Pancreatic Ductal Adenocarcinoma: Predicting Recurrence and Changing Prognosis over Time.
Rieser CJ; Zenati M; Hamad A; Al Abbas AI; Bahary N; Zureikat AH; Zeh HJ; Hogg ME
Ann Surg Oncol; 2018 Nov; 25(12):3483-3491. PubMed ID: 29786131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
